menu
    • menu

    Company profile for Milestone Pharmaceuticals

    NEW Drugs in Dev: 1
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Milestone is a clinical-stage drug development company developing novel small molecule therapeutics based on clinically-validated mechanisms of action for cardiovascular diseases. At its founding, the company assembled a panel of leading pharmaceutical R&D executives (“drug hunters”) each with an average of 30 years experience in drug development. These drug hunters proposed small molecule projects based on clinically-prov...
    Milestone is a clinical-stage drug development company developing novel small molecule therapeutics based on clinically-validated mechanisms of action for cardiovascular diseases. At its founding, the company assembled a panel of leading pharmaceutical R&D executives (“drug hunters”) each with an average of 30 years experience in drug development. These drug hunters proposed small molecule projects based on clinically-proven science that became the foundation of Milestone’s drug development programs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Milestone PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1111 Dr.-Frederik-Philips Blvd., Suite 420 Saint-Laurent, (Quebec) H4M 2X6 Can...
    Telephone
    Telephone
    (514) 336-0444
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://milestonepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Milestone Pharma Launches CARDAMYST Nasal Spray for PSVT in U.S
    Milestone Pharma Launches CARDAMYST Nasal Spray for PSVT in U.S

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225590/0/en/Milestone-Pharmaceuticals-Announces-U-S-Availability-of-CARDAMYST-etripamil-Nasal-Spray-the-First-and-Only-FDA-Approved-Self-Administered-Treatment-for-Adults-with-Paroxysmal-Supra.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Milestone Pharma Submits Etripamil Nasal Spray For PSVT Approval
    Milestone Pharma Submits Etripamil Nasal Spray For PSVT Approval

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213587/0/en/Milestone-Pharmaceuticals-Announces-Acceptance-of-Marketing-Authorization-Application-for-Etripamil-Nasal-Spray-in-PSVT-by-the-European-Medicines-Agency.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Milestone's Long Regulatory Road Ends In Approval For Cardamyst
    Milestone's Long Regulatory Road Ends In Approval For Cardamyst

    15 Dec 2025

    // BIOSPACE

    https://www.biospace.com/fda/milestones-long-regulatory-road-ends-in-approval-for-cardamyst

    BIOSPACE
    15 Dec 2025
    Share Share
    Milestone Pharma ,’s Cardamyst Receives Approval in US
    Milestone Pharma ,’s Cardamyst Receives Approval in US

    12 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218571

    FDA
    12 Dec 2025
    Share Share
    Milestone Gets FDA Nod For CARDAMYST Nasal Spray In PSVT
    Milestone Gets FDA Nod For CARDAMYST Nasal Spray In PSVT

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/13/3204944/0/en/Milestone-Receives-FDA-Approval-of-CARDAMYST-etripamil-as-First-and-Only-Self-Administered-Nasal-Spray-for-Adults-with-Paroxysmal-Supraventricular-Tachycardia-PSVT.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Milestone Pharma Reports Inducement Grants Under Nasdaq Rule 5635
    Milestone Pharma Reports Inducement Grants Under Nasdaq Rule 5635

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3198475/0/en/Milestone-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search